ATE118170T1 - Pharmazeutische zubereitung mit verzögerter freisetzung zur behandlung periodontaler erkrankungen. - Google Patents

Pharmazeutische zubereitung mit verzögerter freisetzung zur behandlung periodontaler erkrankungen.

Info

Publication number
ATE118170T1
ATE118170T1 AT90312249T AT90312249T ATE118170T1 AT E118170 T1 ATE118170 T1 AT E118170T1 AT 90312249 T AT90312249 T AT 90312249T AT 90312249 T AT90312249 T AT 90312249T AT E118170 T1 ATE118170 T1 AT E118170T1
Authority
AT
Austria
Prior art keywords
treatment
sustained release
pharmaceutical preparation
release pharmaceutical
periodontal diseases
Prior art date
Application number
AT90312249T
Other languages
English (en)
Inventor
Nalinkant Chunilal Damani
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27031904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE118170(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE118170T1 publication Critical patent/ATE118170T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90312249T 1989-11-17 1990-11-08 Pharmazeutische zubereitung mit verzögerter freisetzung zur behandlung periodontaler erkrankungen. ATE118170T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43906689A 1989-11-17 1989-11-17
US07/573,604 US5198220A (en) 1989-11-17 1990-08-24 Sustained release compositions for treating periodontal disease

Publications (1)

Publication Number Publication Date
ATE118170T1 true ATE118170T1 (de) 1995-02-15

Family

ID=27031904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312249T ATE118170T1 (de) 1989-11-17 1990-11-08 Pharmazeutische zubereitung mit verzögerter freisetzung zur behandlung periodontaler erkrankungen.

Country Status (14)

Country Link
US (1) US5198220A (de)
EP (1) EP0430474B1 (de)
JP (1) JP3051154B2 (de)
KR (1) KR0156917B1 (de)
AT (1) ATE118170T1 (de)
AU (1) AU648278B2 (de)
CA (1) CA2029046C (de)
DE (1) DE69016755T2 (de)
DK (1) DK0430474T3 (de)
ES (1) ES2067696T3 (de)
FI (1) FI98126C (de)
GR (1) GR3015027T3 (de)
IE (1) IE66371B1 (de)
NZ (1) NZ236113A (de)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
AU2605592A (en) 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
FR2691360B1 (fr) * 1992-05-20 1995-06-30 3P Agence Conseil Compositions pharmaceutiques destinees en particulier au traitement des poches parondontales et procede de fabrication.
NZ247712A (en) * 1992-06-19 1995-04-27 Colgate Palmolive Co Oral composition comprising an anti-bacterial compound, a water-insoluble biodegradable polymer, and an organic solvent
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
GB2280850B (en) * 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
US6001895A (en) * 1993-03-22 1999-12-14 Johnson & Johnson Medical, Inc. Composite surgical material
US6015844A (en) * 1993-03-22 2000-01-18 Johnson & Johnson Medical, Inc. Composite surgical material
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
AU7957994A (en) * 1993-10-01 1995-05-01 Procter & Gamble Company, The Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5639466A (en) * 1994-02-24 1997-06-17 Chronopol, Inc. Method for packaging foodstuffs
DE69524214T3 (de) 1994-05-06 2008-05-15 Pfizer Inc. Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
JPH08113534A (ja) * 1994-10-17 1996-05-07 Ichiro Umeuchi 歯周病治療器具
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6551610B2 (en) 1995-04-13 2003-04-22 Poly-Med, Inc. Multifaceted compositions for post-surgical adhesion prevention
US6413539B1 (en) 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US5942241A (en) * 1995-06-09 1999-08-24 Euro-Celtique, S.A. Formulations and methods for providing prolonged local anesthesia
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
AU733867B2 (en) 1996-06-24 2001-05-31 Euro-Celtique S.A. Methods for providing safe local anesthesia
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
EP1033127A4 (de) * 1997-03-18 2006-07-26 Sunstar Inc Zusammensetzungen zur bildung von festkörperpartikeln
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
IL129951A0 (en) * 1997-07-02 2000-02-29 Euro Celtique Sa Prolonged anesthesia in joints and body spaces
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
US7128927B1 (en) 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6152943A (en) * 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6605294B2 (en) 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
ATE502670T1 (de) * 1998-08-14 2011-04-15 Incept Llc Apparat für die in-situ-bildung von hydrogelen
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6626870B1 (en) 2000-03-27 2003-09-30 Artix Laboratories, Inc. Stoppering method to maintain sterility
US6566144B1 (en) 2000-03-27 2003-05-20 Atrix Laboratories Cover plate for use in lyophilization
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
AU2001271545A1 (en) * 2000-06-30 2002-01-14 The Procter And Gamble Company Promoting whole body health
AU2001271544A1 (en) 2000-06-30 2002-01-14 The Procter And Gamble Company Oral compositions comprising host-response modulating agent
US8470359B2 (en) 2000-11-13 2013-06-25 Qlt Usa, Inc. Sustained release polymer
US20030152637A1 (en) * 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
JP2003231622A (ja) * 2001-12-04 2003-08-19 Kao Corp 口腔用組成物
US7982008B2 (en) 2002-11-27 2011-07-19 David Bar-Or Treatment of diseases and conditions mediated by increased phosphorylation
EP1663196A2 (de) * 2003-09-25 2006-06-07 DMI Biosciences, Inc. Verfahren und produkte unter verwendung von n-acyl-l-aspartsäure
US20050084551A1 (en) 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US20050125015A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Tissue-handling apparatus, system and method
US20050125033A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Wound closure apparatus
CA2576589C (en) * 2004-08-13 2013-11-12 Schering-Plough Ltd. Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
LT1791791T (lt) * 2004-09-27 2019-09-10 Special Water Patents B.V. Vandens valymo būdai ir kompozicijos
US7611494B2 (en) 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
WO2007016310A2 (en) * 2005-07-28 2007-02-08 Indiana University Research & Technology Corporation Niobium oxide compositions, nanostructures, bioactive forms and uses thereof
EP1948236B1 (de) 2005-09-27 2021-03-03 Special Water Patents B.V. Methoden und zusammensetzungen zur behandlung der haut
US20070178220A1 (en) * 2006-01-31 2007-08-02 Karlinsey Robert L Materials and methods for manufacturing amorphous tricalcium phosphate and metal oxide alloys of amorphous tricalcium phosphate and methods of using the same
WO2008059435A2 (en) 2006-11-13 2008-05-22 The Procter & Gamble Company Products and methods for disclosing conditions in the oral cavity
US8298516B2 (en) * 2006-12-22 2012-10-30 Douglas Anderson Calculus dissolving dental composition and methods for using same
US20090088723A1 (en) * 2007-09-28 2009-04-02 Accessclosure, Inc. Apparatus and methods for treating pseudoaneurysms
WO2009134783A1 (en) * 2008-05-02 2009-11-05 The Procter & Gamble Company Products and methods for disclosing conditions in the oral cavity
AU2009324944B2 (en) 2008-11-25 2014-10-16 The Procter & Gamble Company Improved cleaning oral care compositions
JP5890182B2 (ja) 2009-02-12 2016-03-22 インセプト エルエルシー ヒドロゲルプラグによる薬物送達
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
SG173537A1 (en) 2009-04-01 2011-09-29 Colgate Palmolive Co Dentifrice compositions and methods for treating and preventing damage to tooth surfaces
US8434489B2 (en) 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods
US20110104080A1 (en) 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
US20110104081A1 (en) 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
ES2701018T3 (es) 2010-04-01 2019-02-20 Procter & Gamble Control del mal olor de toda la boca mediante una combinación de agentes antibacterianos y desodorantes
CN103153272A (zh) 2010-07-19 2013-06-12 宝洁公司 包含精油化合物的衍生物的组合物以及在个人护理产品中的用途
US20120076734A1 (en) * 2010-09-15 2012-03-29 Jacob Olson Radiopaque antibiotic dental paste and uses thereof
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
US9205150B2 (en) 2011-12-05 2015-12-08 Incept, Llc Medical organogel processes and compositions
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
US20130344120A1 (en) 2012-06-21 2013-12-26 Douglas Craig Scott Mouth Rinse Emulsions
EP2914236B1 (de) 2012-11-05 2017-03-29 The Procter & Gamble Company Wärmebehandlungsverfahren für fällungsieselsäure
US9827082B2 (en) 2013-02-26 2017-11-28 Orthoaccel Technologies, Inc. Fluoride releasing bite plate
JP2016515634A (ja) 2013-04-10 2016-05-30 ザ プロクター アンド ギャンブル カンパニー ポリオルガノシルセスキオキサン粒子を含有する口腔ケア組成物
CA2903419A1 (en) 2013-04-10 2014-10-16 The Procter & Gamble Company Oral care compositions containing polyorganosilsesquioxane particles
WO2014169109A1 (en) 2013-04-10 2014-10-16 The Procter & Gamble Company Oral care compositions containing polyorganosilsesquioxane particles
WO2015178565A1 (ko) 2014-05-21 2015-11-26 주식회사 루멘스 교류전원을 이용하는 led 조명장치
JP6851366B2 (ja) 2015-08-03 2021-03-31 アイエスピー インヴェストメンツ エルエルシー ビニルアルコールエーテルから誘導されたポリマーを含むパーソナルケア組成物、およびその用途
ES2913120T3 (es) 2015-08-04 2022-05-31 Isp Investments Llc Polímeros derivados de éteres de alcohol vinílico aminofuncionales y aplicaciones de los mismos
WO2017106467A1 (en) 2015-12-15 2017-06-22 Gontarz John A Oral care formulation and method for the removal of tartar and plaque from teeth
BR112020003233B1 (pt) 2017-12-20 2023-11-07 Firmenich S.A. Composições para cuidado oral
EP3658109B1 (de) 2017-12-21 2022-12-07 Firmenich SA Zusammensetzungen zur kühlung und geschmacksverstärkung
EP3958983A1 (de) 2019-04-26 2022-03-02 The Procter & Gamble Company Reduktion von zahnverfärbung aus kationischen antimikrobiellen mitteln
IL292156B2 (en) 2019-10-17 2026-05-01 Givaudan Sa Modified azacils as TRMP8 modulators
WO2021102896A1 (en) 2019-11-29 2021-06-03 Givaudan Sa Organic compounds
WO2021174475A1 (en) 2020-03-05 2021-09-10 Givaudan Sa Organic compounds
GB202012170D0 (en) 2020-08-05 2020-09-16 Givaudan Sa Organic compounds
WO2022170519A1 (en) 2021-02-09 2022-08-18 Givaudan Sa Organic compounds
GB202105661D0 (en) 2021-04-21 2021-06-02 Givaudan Sa Organic compounds
GB202303792D0 (en) 2023-03-15 2023-04-26 Givaudan Sa Cosmetic composition
WO2026132198A1 (en) 2024-12-20 2026-06-25 Givaudan Sa Oral care compositions

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608057A (en) * 1967-10-03 1971-09-21 Amicon Corp Process for making contact lenses
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US4048256A (en) * 1976-06-01 1977-09-13 American Cyanamid Company Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product
US4328204A (en) * 1977-03-02 1982-05-04 Ethicon, Inc. Absorbable polymer-drug compounds and method for making same
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
US4624256A (en) * 1985-09-11 1986-11-25 Pfizer Hospital Products Group, Inc. Caprolactone polymers for suture coating
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
JPH0617300B2 (ja) * 1986-09-22 1994-03-09 サンスタ−株式会社 歯周疾患治療用組成物
DE3708916A1 (de) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
JPH0645535B2 (ja) * 1987-05-20 1994-06-15 サンスタ−株式会社 歯槽骨代謝治療用組成物
IL86802A0 (en) * 1987-06-30 1988-11-30 Vipont Pharma Drug delivery devices
US5005074A (en) * 1989-11-17 1991-04-02 Rca Licensing Corporation Adaptive multistandard video comb filter
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease

Also Published As

Publication number Publication date
EP0430474A1 (de) 1991-06-05
DE69016755T2 (de) 1995-09-21
NZ236113A (en) 1993-05-26
GR3015027T3 (en) 1995-05-31
DK0430474T3 (da) 1995-04-03
FI905683A0 (fi) 1990-11-16
US5198220A (en) 1993-03-30
DE69016755D1 (de) 1995-03-23
KR0156917B1 (ko) 1998-11-16
FI905683L (fi) 1991-05-18
AU648278B2 (en) 1994-04-21
EP0430474B1 (de) 1995-02-08
ES2067696T3 (es) 1995-04-01
IE904147A1 (en) 1991-05-22
FI98126B (fi) 1997-01-15
CA2029046A1 (en) 1991-05-18
JPH03271219A (ja) 1991-12-03
JP3051154B2 (ja) 2000-06-12
FI98126C (fi) 1997-04-25
AU6667690A (en) 1991-05-23
IE66371B1 (en) 1995-12-27
CA2029046C (en) 1995-03-28
KR910009243A (ko) 1991-06-28

Similar Documents

Publication Publication Date Title
DE69016755D1 (de) Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen.
ATE151282T1 (de) Zusammensetzungen mit verzögerter wirkstoffabgabe zur behandlung periodontaler erkrankungen
EP0671175A3 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen.
DE69025271D1 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
DE3781928D1 (de) Arzneimittel mit verzoegerter freisetzung.
DE68915132D1 (de) Verfahren zur Behandlung von Periodontitis durch protrahierte Wirkstoffabgabe von Arzneimitteln in der Zahnhöhle, Zusammensetzung davon und Vorrichtung zur Verabreichung.
NO951630D0 (no) Fremgangsmåte for administrering av azithromycin
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
ATE88633T1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked